Transcatheter aortic valve replacement (TAVR) is a newer, minimally invasive approach for treating aortic valve disease. The TAVR procedure has expanded the possibilities for replacing the aortic valve, and we continue to help shape its evolution.
For people who cannot undergo surgery to replace narrowed valves, TAVR first provided an effective option where none existed. Recently, it also presented a minimally invasive alternative for people who could endure an operation, but faced moderate risk. Now, we are investigating its possible use in an even wider range of people.